Skip to main content
. 2015 Apr 28;10:107. doi: 10.1186/s13014-015-0404-x

Figure 3.

Figure 3

Visualization of (a) equivalent dose and (b), (c), and (d) lifetime risks of second cancer incidence based on different dose-risk relationships (LNT: linear non-threshold model, LPLA(10): linear plateau model with bending point at 10 Sv, LEXP(10): linear exponential model with bending point at 10 Sv) on sagittal and coronal slices for a 67-year-old man who received photon VMAT prostate treatment.